“元气通”中药药枕熏蒸预防颈椎病对照观察及疗效评价

Controlled observation and efficacy evaluation of “Yuanqitong” Chinese herbal medicated pillow with fumigation in the prevention of cervical spondylosis

目的观察"元气通"中药药枕熏蒸对颈椎病的预防作用。方法将符合观察条件的100例颈椎病高危人群随机分为对照组和观察组,每组各50例。对照组实施健康宣教+运动指导;观察组在实施健康宣教+运动指导基础上,使用"元气通"中药药枕熏蒸,每天1次,3个月为1疗程。治疗1个疗程后,对疼痛分级指数(PRI)、视觉模拟量表(VAS)和现有疼痛强度(PPI)进行评分,并根据证候评分统计疗效。结果两组干预后各项评分均较干预前明显降低(均P<0.01),且干预后观察组PRI较对照组降低更加明显(P<0.01),而VAS、PPI评分组间差异无统计学意义(均P>0.05);对照组总有效率为88%,观察组总有效率为94%,观察组证候改善疗效优于对照组(P<0.01)。结论 "元气通"中药药枕熏蒸可明显降低颈椎病高危人群的证候群评分,对预防颈椎病发生发展有良好的效果。

Objective To observe the preventive effects of ＂Yuanqitong＂ Chinese herbal medicated pillow with fumigation for cervical spondylosis. Methods 100 high-risk patients with cervical spondylosis who met the observation condition were randomly divided into the control group and observation group ,50 cases in each group. The control group was treated with health education and sports instruction, the observation group was treated with ＂Yuanqitong＂ Chinese herbal medicated pillow for fumigation once a day based on the treatment for the control group, with a course of 3 months. After treatment for 3 months, the scores of pain rating index （PRI）, visual analogue scale （VAS） and present pain intensity （PPI） were evaluated, and the efficacy was compared according to the symptom scores. Results After treatment, all the scores were obviously decreased in both groups compared with treatment before （P 〈 0.01 ） , and the PRI score in the observation group was significantly lower than that in the control group （ P 〈 0.01 ）, while there were no significant differences on the scores of VAS and PPI between the two groups （ P 〉 0.05 ）. The total effective rate of the control group was 88% , and the total effective rate of the observation group was 94%, the efficacy of the observation group on syndrome improvement was better than that of the control group （ P 〈 0.01 ）. Conclusion ＂Yuanqitong＂ Chinese herbal medicated pillow with fumigation can significantly decrease the syndrome scores of high-risk population with cervical spondylosis, which shows good efficacy in the prevention of the occurrence and development of cervical spondylosis.